The Marketing Minute: Staying Positive When the Market Isn’t
Marcy’s Musings: Continuing to Invent the Future With SEL
It’s Only Common Sense: Why Failure Is an Opportunity for Growth
Autonomous Healthcare Awarded DARPA Contract to Develop Hemorrhage Control Technology
May 24, 2021 | PRNewswireEstimated reading time: Less than a minute
Autonomous Healthcare, Inc. has been awarded a Small Business Innovation Research (SBIR) Phase I contract by the Defense Advanced Research Projects Agency (DARPA) to commercialize an automated system for hemorrhage control and resuscitation at the point of injury.
Non-compressible torso hemorrhage, which results from bleeding that cannot be controlled with a tourniquet or application of direct pressure, is the leading cause of death among survivable battlefield injuries. Additionally, within the civilian US sectors, bleeding from trauma creates a significant death toll among survivable injuries. Autonomous Healthcare aims to develop a technology that will provide fully-automated partial resuscitative endovascular balloon occlusion of the aorta (pREBOA), allowing a set amount of blood past the balloon and mitigating the ischemia-reperfusion metabolic injury.
"This award provides further validation for Autonomous Healthcare's vision to revolutionize emergency and critical care by introducing closed-loop control technologies," said Dr. Behnood Gholami, Co-Founder and CEO of Autonomous Healthcare. "An automated system to provide pREBOA will create a better opportunity for use in trauma scenarios as well as make the procedure more widely available to medics and first responders."
Share on:
Testimonial
"Our marketing partnership with I-Connect007 is already delivering. Just a day after our press release went live, we received a direct inquiry about our updated products!"
Rachael Temple - AlltematedSuggested Items
Off to the Races: DRBE Develops World’s Largest Real-time EW Test Range
08/19/2025 | DARPAThe U.S. Department of Defense faces an increasingly complex electromagnetic environment, in which rapid advances in radar and electronic warfare (EW) demand new tools for development, testing, and training.
Alta Resource Technologies Advances to Final Phase of DARPA’s EMBER Program
08/07/2025 | BUSINESS WIREAlta Resource Technologies announced its selection as a primary collaborator in Phase 3 of the Defense Advanced Research Projects Agency (DARPA)’s Environmental Microbes as a BioEngineering Resource (EMBER) program.
Stephen Winchell Appointed DARPA Director
06/02/2025 | DARPAStephen Winchell was sworn in today as the 24th director of the Defense Advanced Research Projects Agency.
Defense Speak Interpreted: Is There Still a CHIPS Act?
05/20/2025 | Dennis Fritz -- Column: Defense Speak InterpretedWhen I proposed my Defense Speak column topics for 2025 in February, there was a slight hint of doubt about the status of the CHIPS Act. But now? The CHIPS and Science Act is a multi-part $280 billion authorization by the U.S. Congress that President Biden signed into law on Aug. 9, 2022. Notice, I did not say appropriation. That’s because the actual appropriation was $52.7 billion.
DARPA, State of Maryland Sign Agreement to Propel Quantum Research
05/05/2025 | DARPADARPA and the State of Maryland have established a cooperative effort, the Capital Quantum Benchmarking Hub, to test and evaluate quantum computing prototypes and systems for national security and commercial applications.